Molecular characterization of deletion breakpoints in adults with 22q11 deletion syndrome

• Published in: Human genetics Vol. 120; no. 6; pp. 837 - 845
• Main Authors: Weksberg, Rosanna, Stachon, Andrea C, Squire, Jeremy A, Moldovan, Laura, Bayani, Jane, Meyn, Stephen, Chow, Eva, Bassett, Anne S
• Format: Journal Article
• Language: English
• Published: Germany Springer 01.02.2007; Springer Nature B.V
• Subjects: Addictions; Adult; Adults; Chromosome Breakage; Chromosome Deletion; Chromosome Mapping; Chromosomes, Human, Pair 22 - genetics; Congenital diseases; Female; Genetic disorders; Hospitals; Humans; In Situ Hybridization, Fluorescence; Male; Mental disorders; Mental health; Metabolism; Phenotype; Polymerase Chain Reaction; Psychosis; Repetitive Sequences, Nucleic Acid; Schizophrenia; Schizophrenia - genetics; Syndrome; Canada
• ISSN: 0340-6717; 1432-1203
• DOI: 10.1007/s00439-006-0242-x

22q11 Deletion syndrome (22q11DS) is a common microdeletion syndrome with variable expression, including congenital and later onset conditions such as schizophrenia. Most studies indicate that expression does not appear to be related to length of the deletion but there is limited information on the endpoints of even the common deletion breakpoint regions in adults. We used a real-time quantitative PCR (qPCR) approach to fine map 22q11.2 deletions in 44 adults with 22q11DS, 22 with schizophrenia (SZ; 12 M, 10 F; mean age 35.7 SD 8.0 years) and 22 with no history of psychosis (NP; 8 M, 14 F; mean age 27.1 SD 8.6 years). QPCR data were consistent with clinical FISH results using the TUPLE1 or N25 probes. Two subjects (one SZ, one NP) negative for clinical FISH had atypical 22q11.2 deletions confirmed by FISH using the RP11-138C22 probe. Most (n = 34; 18 SZ, 16 NP) subjects shared a common 3 Mb hemizygous 22q11.2 deletion. However, eight subjects showed breakpoint variability: a more telomeric proximal breakpoint (n = 2), or more centromeric (n = 3) or more telomeric distal breakpoint (n = 3). One NP subject had a proximal nested 1.4 Mb deletion. COMT and TBX1 were deleted in all 44 subjects, and PRODH in 40 subjects (19 SZ, 21 NP). The results delineate proximal and distal breakpoint variants in 22q11DS. Neither deletion extent nor PRODH haploinsufficiency appeared to explain the clinical expression of schizophrenia in the present study. Further studies are needed to elucidate the molecular basis of schizophrenia and clinical heterogeneity in 22q11DS.